Reminder: Invitation to Roche’s Full Year Results 2023 Presentation

January 25, 2024 (press release) –

Roche will publish its Full Year Results of 2023 prior to the opening of the Swiss Stock Exchange on Thursday, 1 February 2024. 07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before) Release will be e-mailed and posted on the Roche IR website > click here Presentation slides will be posted on the Roche IR website > click here 14:00 – 16:00 CET / 13:00 – 15:00 GMT 08:00 – 10:00 AM EST / 05:00 - 07:00 AM PST The webinar will start with presentations by senior management, followed by a Q&A session. Presenters: Thomas Schinecker, CEO Roche Group Teresa Graham, CEO Roche Pharmaceuticals Matt Sause, CEO Roche Diagnostics  Alan Hippe, Chief Financial and IT Officer Roche We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.* Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com. A replay of the webinar will be available via > ir.roche.com *privacy notice Best regards,
Bruno Eschli Head of Investor Relations

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.